Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hyperuricemia is an independent competing risk factor for atrial fibrillation
Masanari Kuwabara, Koichiro Niwa, Shuzo Nishihara, et al.
International Journal of Cardiology (2016) Vol. 231, pp. 137-142
Closed Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Physiology of Hyperuricemia and Urate-Lowering Treatments
Caroline Benn, Vivek Dua, Rachel Gurrell, et al.
Frontiers in Medicine (2018) Vol. 5
Open Access | Times Cited: 273
Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective
Wei Yu, Jidong Cheng
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 254
Hyperuricemia and endothelial function: From molecular background to clinical perspectives
Tatsuya Maruhashi, Ichiro Hisatome, Yasuki Kihara, et al.
Atherosclerosis (2018) Vol. 278, pp. 226-231
Open Access | Times Cited: 193
Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases
Masanari Kuwabara, Koichiro Niwa, Ichiro Hisatome, et al.
Hypertension (2017) Vol. 69, Iss. 6, pp. 1036-1044
Open Access | Times Cited: 191
Different Risk for Hypertension, Diabetes, Dyslipidemia, and Hyperuricemia According to Level of Body Mass Index in Japanese and American Subjects
Masanari Kuwabara, Remi Kuwabara, Koichiro Niwa, et al.
Nutrients (2018) Vol. 10, Iss. 8, pp. 1011-1011
Open Access | Times Cited: 173
Hyperuricemia and Cardiovascular Disease
Shuangshuang Zhang, Yong Wang, Jinsong Cheng, et al.
Current Pharmaceutical Design (2019) Vol. 25, Iss. 6, pp. 700-709
Open Access | Times Cited: 165
Uric acid in metabolic syndrome: Does uric acid have a definitive role?
Sidar Çöpür, Atalay Demiray, Mehmet Kanbay
European Journal of Internal Medicine (2022) Vol. 103, pp. 4-12
Closed Access | Times Cited: 154
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono K, Yu‐ki Iwasaki, Masaharu Akao, et al.
Circulation Journal (2022) Vol. 86, Iss. 11, pp. 1790-1924
Open Access | Times Cited: 85
Update in uric acid, hypertension, and cardiovascular diseases
Masanari Kuwabara, Takahide Kodama, Ryusuke Ae, et al.
Hypertension Research (2023) Vol. 46, Iss. 7, pp. 1714-1726
Closed Access | Times Cited: 46
Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan
Masanari Kuwabara, Claudio Borghi, Arrigo F.G. Cicero, et al.
International Journal of Cardiology (2018) Vol. 261, pp. 183-188
Closed Access | Times Cited: 134
Impact of Hyper- and Hypo-Uricemia on Kidney Function
Junichiro Miake, Ichiro Hisatome, Katsuyuki Tomita, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1258-1258
Open Access | Times Cited: 25
“Metabolically Healthy” Obesity and Hyperuricemia Increase Risk for Hypertension and Diabetes: 5‐year Japanese Cohort Study
Masanari Kuwabara, Remi Kuwabara, Ichiro Hisatome, et al.
Obesity (2017) Vol. 25, Iss. 11, pp. 1997-2008
Open Access | Times Cited: 76
Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases.
Hongsha Wang, Haifeng Zhang, Lin Sun, et al.
PubMed (2018) Vol. 10, Iss. 9, pp. 2749-2763
Closed Access | Times Cited: 76
Elevated Serum Uric Acid Level Predicts Rapid Decline in Kidney Function
Masanari Kuwabara, Petter Bjornstad, Ichiro Hisatome, et al.
American Journal of Nephrology (2017) Vol. 45, Iss. 4, pp. 330-337
Open Access | Times Cited: 66
The Key Role of Uric Acid in Oxidative Stress, Inflammation, Fibrosis, Apoptosis, and Immunity in the Pathogenesis of Atrial Fibrillation
Yawen Deng, Fei Liu, Xiaolei Yang, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 54
Correlation between serum uric acid to high-density lipoprotein cholesterol ratio and atrial fibrillation in patients with NAFLD
Gaizhen Liu, Qi Zhang, Meng Zhou, et al.
PLoS ONE (2024) Vol. 19, Iss. 6, pp. e0305952-e0305952
Open Access | Times Cited: 7
Prevalence and complications of hypouricemia in a general population: A large-scale cross-sectional study in Japan
Masanari Kuwabara, Koichiro Niwa, Akira Ohtahara, et al.
PLoS ONE (2017) Vol. 12, Iss. 4, pp. e0176055-e0176055
Open Access | Times Cited: 57
The Optimal Range of Serum Uric Acid for Cardiometabolic Diseases: A 5-Year Japanese Cohort Study
Masanari Kuwabara, Ichiro Hisatome, Koichiro Niwa, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 942-942
Open Access | Times Cited: 49
Cohort Study of Repeated Measurements of Serum Urate and Risk of Incident Atrial Fibrillation
Shanshan Li, Cheng Jin, Liufu Cui, et al.
Journal of the American Heart Association (2019) Vol. 8, Iss. 13
Open Access | Times Cited: 47
Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease ― Japanese Guideline on the Management of Asymptomatic Hyperuricemia ―
Ichiro Hisatome, Peili Li, Junichiro Miake, et al.
Circulation Journal (2020) Vol. 85, Iss. 2, pp. 130-138
Open Access | Times Cited: 42
Nonlinearity association between hyperuricemia and all-cause mortality in patients with chronic kidney disease
Yafei Liu, Liang Han, Yin-Hong Geng, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Progress of uric acid in cardiovascular disease
Tian-ming Gan, Yu-yu Ye, Guan-lian Mo, et al.
Cardiovascular Endocrinology & Metabolism (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 5
Silencing TXNIP ameliorates high uric acid-induced insulin resistance via the IRS2/AKT and Nrf2/HO-1 pathways in macrophages
Wei Yu, Chunjuan Chen, Wanling Zhuang, et al.
Free Radical Biology and Medicine (2021) Vol. 178, pp. 42-53
Closed Access | Times Cited: 32
The Association Between Ambient Air Pollution and Atrial Fibrillation
Miao Chen, Jianqiang Zhao, Chengui Zhuo, et al.
International Heart Journal (2021) Vol. 62, Iss. 2, pp. 290-297
Open Access | Times Cited: 31
Comparison between febuxostat and allopurinol uric acid-lowering therapy in patients with chronic heart failure and hyperuricemia: a multicenter randomized controlled trial
Satoshi Suzuki, Akiomi Yoshihisa, Tetsuro Yokokawa, et al.
Journal of International Medical Research (2021) Vol. 49, Iss. 12
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top